Regulation of the cytokine network by interferon: a potential mechanism of interferon in chronic myelogenous leukemia.
Peschel
C
C
Department of Internal Medicine, Johannes-Gutenberg University Medical Center, Mainz, Germany.
Aman
M J
MJ
Rudolf
G
G
Aulitzky
W E
WE
Huber
C
C
D001853:Bone Marrow / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D002478:Cells, Cultured; D016207:Cytokines / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology* / Q000627:therapeutic use; D053590:Interleukin 1 Receptor Antagonist Protein; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D012795:Sialoglycoproteins / Q000097:blood
D016207:Cytokines; C507763:IL1RN protein, human; D016898:Interferon-alpha; D053590:Interleukin 1 Receptor Antagonist Protein; D012795:Sialoglycoproteins